Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Other financing activities (2024 - 2025)

Caris Life Sciences has reported Other financing activities over the past 2 years, most recently at $5.7 million for Q3 2025.

  • Quarterly results put Other financing activities at $5.7 million for Q3 2025, up 945.2% from a year ago — trailing twelve months through Dec 2025 was $6.2 million (changed N/A YoY), and the annual figure for FY2025 was $7.7 million, up 628.05%.
  • Other financing activities for Q3 2025 was $5.7 million at Caris Life Sciences, up from $25000.0 in the prior quarter.
  • Over the last five years, Other financing activities for CAI hit a ceiling of $5.7 million in Q3 2025 and a floor of $25000.0 in Q4 2024.